- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.78 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x PLM: PALMITIC ACID(Non-covalent)
- 3 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-functional Binders)
- 3 x VDW: [(2~{S})-5-[[(2~{R})-1-(2-hydroxy-2-oxoethylamino)-1-oxidanylidene-3-sulfanyl-propan-2-yl]amino]-1-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]azanium(Non-covalent)
VDW.4: 16 residues within 4Å:- Chain A: R.58, N.62, E.65, Y.66, Y.100, Y.104, R.111, L.115
- Chain C: S.30, V.33, I.34, R.37, P.44, P.45, Q.60
- Ligands: 01.5
9 PLIP interactions:7 interactions with chain A, 2 interactions with chain C- Hydrophobic interactions: A:Y.66
- Hydrogen bonds: A:N.62, A:N.62, A:N.62, A:N.62, A:R.111, C:Q.60
- Salt bridges: A:R.58, C:R.37
VDW.9: 16 residues within 4Å:- Chain A: S.30, V.33, I.34, R.37, P.44, P.45, Q.60
- Chain B: R.58, N.62, E.65, Y.66, Y.100, Y.104, R.111, L.115
- Ligands: 01.10
9 PLIP interactions:7 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:Y.66
- Hydrogen bonds: B:N.62, B:N.62, B:N.62, B:N.62, B:R.111, A:Q.60
- Salt bridges: B:R.58, A:R.37
VDW.14: 16 residues within 4Å:- Chain B: S.30, V.33, I.34, R.37, P.44, P.45, Q.60
- Chain C: R.58, N.62, E.65, Y.66, Y.100, Y.104, R.111, L.115
- Ligands: 01.15
9 PLIP interactions:2 interactions with chain B, 7 interactions with chain C- Hydrogen bonds: B:Q.60, C:N.62, C:N.62, C:N.62, C:N.62, C:R.111
- Salt bridges: B:R.37, C:R.58
- Hydrophobic interactions: C:Y.66
- 3 x 01: 1-[3,4-bis(fluoranyl)phenyl]-9-[6-[2,2,2-tris(fluoranyl)ethoxy]pyrimidin-4-yl]-1,9-diazaspiro[5.5]undecan-2-one
01.5: 14 residues within 4Å:- Chain A: Y.66, L.69, L.115, A.119, L.122, W.123
- Chain C: V.23, L.24, A.27, Y.28, S.30, L.31
- Ligands: VDW.4, PLM.13
8 PLIP interactions:2 interactions with chain C, 6 interactions with chain A- Hydrophobic interactions: C:A.27, C:L.31, A:Y.66, A:L.69, A:L.115, A:A.119, A:L.122
- pi-Stacking: A:W.123
01.10: 14 residues within 4Å:- Chain A: V.23, L.24, A.27, Y.28, S.30, L.31
- Chain B: Y.66, L.69, L.115, A.119, L.122, W.123
- Ligands: PLM.3, VDW.9
8 PLIP interactions:6 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:Y.66, B:L.69, B:L.115, B:A.119, B:L.122, A:A.27, A:L.31
- pi-Stacking: B:W.123
01.15: 14 residues within 4Å:- Chain B: V.23, L.24, A.27, Y.28, S.30, L.31
- Chain C: Y.66, L.69, L.115, A.119, L.122, W.123
- Ligands: PLM.8, VDW.14
8 PLIP interactions:2 interactions with chain B, 6 interactions with chain C- Hydrophobic interactions: B:A.27, B:L.31, C:Y.66, C:L.69, C:L.115, C:A.119, C:L.122
- pi-Stacking: C:W.123
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Thoma, G. et al., Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 Synthase. J.Med.Chem. (2025)
- Release Date
- 2025-02-26
- Peptides
- Leukotriene C4 synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.78 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x PLM: PALMITIC ACID(Non-covalent)
- 3 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-functional Binders)
- 3 x VDW: [(2~{S})-5-[[(2~{R})-1-(2-hydroxy-2-oxoethylamino)-1-oxidanylidene-3-sulfanyl-propan-2-yl]amino]-1-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]azanium(Non-covalent)
- 3 x 01: 1-[3,4-bis(fluoranyl)phenyl]-9-[6-[2,2,2-tris(fluoranyl)ethoxy]pyrimidin-4-yl]-1,9-diazaspiro[5.5]undecan-2-one
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Thoma, G. et al., Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 Synthase. J.Med.Chem. (2025)
- Release Date
- 2025-02-26
- Peptides
- Leukotriene C4 synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.